Autologous adipose-derived stromal cells for Parkinson's disease

Adipose-derived stromal cells (ASCs) can be used for treatment of Parkinson's disease. This study aims to assess the safety and efficacy of ASC implantation toward improving the disease pathology of Parkinson's disease. ASCs are derived from the patient's adipose-derived tissue.